Total Funding
64
61
Total FundingSeed raised
Growth Score 64 in past quarter
-2 pts
Heat Score 61 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
111861
The first anti-inflammaging company to fight low-grade chronic inflammation to avoid premature aging and prevent diseases
- Fabio Cavalli: Co-Founder and CEO ad interimPast Role: mondoBIOTECH, Founder, CEO and Chief Business Architect
- Patrick Pozzorini: Co-Founder and CFO
About the Company
Mymeleon Group provides the first anti-inflammaging solution to profile and calculate the personalized Inflammaging Index (AGI®) in a modern noninvasive way, via API for B2B clients with large communities of users.
We offer movement, nutrition, environment and cognition tips to protect end-users from chronic diseases and premature aging by
reducing low-grade chronic inflammation, the “secret killer”.